Nisa Investment Advisors
AMLX icon

Nisa Investment Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Nisa Investment Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9K Buy
1,163
+241
+26% +$3.73K ﹤0.01% 2198
2026
Q1 		$12.8K Hold
922
– – ﹤0.01% 2150
2025
Q4 		$11.1K Buy
922
+637
+224% +$8.65K ﹤0.01% 2167
2025
Q3 		$3.87K Hold
285
– – ﹤0.01% 2489
2025
Q2 		$1.83K Hold
285
– – ﹤0.01% 2624
2025
Q1 		$1.01K Sell
285
-210
-42% -$747 ﹤0.01% 2637
2024
Q4 		$1.87K Sell
495
-250
-34% -$1.18K ﹤0.01% 2505
2024
Q3 		$2.41K Buy
745
+460
+161% +$1.03K ﹤0.01% 2359
2024
Q2 		$542 Buy
285
+275
+2,750% +$533 ﹤0.01% 2665
2024
Q1 		$28 Sell
10
-24
-71% -$314 ﹤0.01% 2767
2023
Q4 		$500 Buy
34
+18
+113% +$276 ﹤0.01% 2406
2023
Q3 		$293 Sell
16
-2
-11% -$42 ﹤0.01% 2617
2023
Q2 		$388 Sell
18
-8
-31% -$216 ﹤0.01% 2611
2023
Q1 		$1K Hold
26
– – ﹤0.01% 2345
2022
Q4 		$1K Hold
26
– – ﹤0.01% 2390
2022
Q3 		$1K Buy
+26
New +$649 ﹤0.01% 2387

Other funds holding AMLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Nisa Investment Advisors's AMLX Position: Q2 2026 in Review

Nisa Investment Advisors increased its Amylyx Pharmaceuticals (AMLX) stake by 26% in Q2 2026, buying an estimated $3.73K and bringing the position to 1,163 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Nisa Investment Advisors first reported a position in AMLX in Q3 2022 and has held it in 16 quarters since. 58 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Nisa Investment Advisors held 1,163 shares of Amylyx Pharmaceuticals worth $20.9K as of Q2 2026.
  • Nisa Investment Advisors bought 241 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $3.73K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2198 holding.
  • Nisa Investment Advisors first reported a position in Amylyx Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 58 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.